India's government will not buy COVID-19 shots from Pfizer /BioNTech and Moderna , three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped.
That essentially means the globally popular vaccines, which their makers have pledged not to sell to private parties during the pandemic, will not be available for now in the world's two most populous countries - China and India.
A second source said: "The government will not buy Pfizer and Moderna vaccines. They are free to have private tie-ups after necessary regulatory clearances. But sovereign indemnity is clearly something we can't give". The company reiterated that "during the pandemic phase, it would supply the COVID-19 vaccine only to central governments and supra-national organisations".Moderna, through its Indian partner Cipla
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11The drugmaker said it will seek emergency use authorization for this age group in the U.S. by the end of the month.
Read more »
Pfizer says COVID-19 vaccine safe, effective for kids ages 5 to 11Pfizer and BioNTech released data saying its vaccine is safe and effective for kids 5-11.
Read more »
Pfizer says COVID-19 vaccine works in kids ages 5 to 11Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.
Read more »
Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11Pfizer Inc. undefined and German partner BioNTech SE undefined on Monday announced positive results in a Phase 2/3 trial of their COVID-19 vaccine in...
Read more »
Pfizer COVID-19 vaccine works in younger children, drugmaker saysPfizer says its COVID-19 vaccine is safe and likely to work in younger children, and it's planning to ask for permission to use it in kids as young as 5
Read more »